1-10 of 10
Won-Seog Kim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: Results from PETAL consortium

Jessy Xinyi Han, Min Jung Koh, Leora Boussi, Mark Sorial, Sean Michael McCabe, Luke Peng, Shambhavi Singh, Ijeoma Julie Eche-Ugwu, Judith Gabler, Maria J. Fernandez Turizo, Caroline T MacVicar, Aditya Ramesh Garg, Alexander Disciullo, Kusha Chopra, Alexandra W. Lenart, Emmanuel Nwodo, Jeffrey A. Barnes, Min Ji Koh, Eliana C M Miranda, Carlos Sergio Chiattone, Robert N Stuver, Steven M Horwitz, Mwanasha H Merrill, Eric D. Jacobsen, Martina Manni, Monica Civallero, Tetiana Skrypets, Athina Lymboussaki, Massimo Federico, Yu Ri Kim, Jin Seok Kim, Jae Yong Cho, Thomas Eipe, Tanuja Shet, Dr., Sridhar Epari, Alok Shetty, Saswata Saha, Hasmukh Jain, Dr., Manju Sengar, MD, DM, Carrie Van Der Weyden, H Miles Prince, Ramzi Hamouche, Tinatin Muradashvili, Francine M Foss, Marianna Gentilini, Beatrice casadei, Pier Luigi Zinzani, Takeshi Okatani, Noriaki Yoshida, Sang Eun Yoon, Won Seog Kim, Girisha Panchoo, Zainab Mohamed, Estelle Verburgh, Jackielyn Cuenca Alturas, Mubarak Al-Mansour, Josie Ford, Maria Elena Cabrera, Amy Ku, Govind Bhagat, Helen Ma, Ahmed Sawas, Khyati Maulik Kariya, Makoto Iwasaki, Forum Bhanushali, Owen A. O'Connor, Enrica Marchi, Changyu Shen, Devavrat Shah, Salvia Jain
Journal: Blood Advances
Blood Adv bloodadvances.2024014674.
https://doi.org/10.1182/bloodadvances.2024014674
Published: 2024
Includes: Supplemental data
Journal Articles

CHRONOS-4: phase 3 study of copanlisib plus rituximab-based immunochemotherapy in relapsed indolent B-cell lymphoma

Clinical Trials & Observations
Pier Luigi Zinzani, Huaqing Wang, Jifeng Feng, Tae Min Kim, Rong Tao, Huilai Zhang, Laura Fogliatto, Clara Maluquer Artigal, Muhit Özcan, Eduardo Yanez, Won Seog Kim, Dmitry Kirtbaya, Iryna Kriachok, Felipe Maciel, Hongwei Xue, Krimo Bouabdallah, Charles Phelps, Shalini Chaturvedi, Anke Weispfenning, Peter N. Morcos, Fatuma Odongo, Viktoriya Buvaylo, Barrett H. Childs, Martin Dreyling, Matthew Matasar, Paola Ghione
Journal: Blood Advances
Blood Adv (2024) 8 (18): 4866–4876.
https://doi.org/10.1182/bloodadvances.2024013236
Published: 2024
Includes: Supplemental data
Journal Articles

Phase 2 trial of the farnesyltransferase inhibitor tipifarnib for relapsed/refractory peripheral T-cell lymphoma

Clinical Trials & Observations
Thomas Witzig, Lubomir Sokol, Won Seog Kim, Fátima de la Cruz Vicente, Alejandro Martín García-Sancho, Ranjana Advani, Jose Maria Roncero Vidal, Raquel de Oña Navarrete, Ana Marín-Niebla, Antonia Rodriguez Izquierdo, María José Terol, Eva Domingo-Domenech, Andrew Saunders, Nawal Bendris, Julie Mackey, Mollie Leoni, Francine Foss
Journal: Blood Advances
Blood Adv (2024) 8 (17): 4581–4592.
https://doi.org/10.1182/bloodadvances.2024012806
Published: 2024
Includes: Supplemental data
Journal Articles

The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network

Greg Hapgood, Monica Civallero, Yana Stepanishyna, Julie Vose, Monica Elena Cabrera, Ranjana H. Advani, Stefano A. Pileri, Martina Manni, Steven M. Horwitz, Francine M. Foss, Felicitas Hitz, John Radford, Ivan Dlouhy, Carlos Chiattone, Won Seog Kim, Tetiana Skrypets, Arnon Nagler, Judith Trotman, Stefano Luminari, Massimo Federico
Journal: Blood Advances
Blood Adv (2023) 7 (17): 5047–5054.
https://doi.org/10.1182/bloodadvances.2023010037
Published: 2023
Includes: Supplemental data
Journal Articles

Darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: results of an Asian phase 2 study

Clinical Trials & Observations
Won-Seog Kim, Noriko Fukuhara, Dok-Hyun Yoon, Kazuhito Yamamoto, Toshiki Uchida, Eiju Negoro, Koji Izutsu, Yasuhito Terui, Hideaki Nakajima, Kiyoshi Ando, Youko Suehiro, Hye Jin Kang, Po-Shen Ko, Fumiko Nagahama, Yusuke Sonehara, Hirokazu Nagai, Hwei-Fang Tien, Yok-Lam Kwong, Kensei Tobinai
Journal: Blood Advances
Blood Adv (2023) 7 (17): 4903–4912.
https://doi.org/10.1182/bloodadvances.2022008615
Published: 2023
Journal Articles

CD47 overexpression is common in intestinal non-GCB type diffuse large B-cell lymphoma and associated with 18q21 gain

Junhun Cho, Sang Eun Yoon, Seok Jin Kim, Young Hyeh Ko, Won Seog Kim
Journal: Blood Advances
Blood Adv (2022) 6 (24): 6120–6130.
https://doi.org/10.1182/bloodadvances.2021006305
Published: 2022
Journal Articles

Long-term efficacy and safety of CT-P10 or rituximab in untreated advanced follicular lymphoma: a randomized phase 3 study

Clinical Trials & Observations
Christian Buske, Wojciech Jurczak, Juan-Manuel Sancho, Edvard Zhavrid, Jin Seok Kim, José-Ángel Hernández-Rivas, Aliaksandr Prokharau, Mariana Vasilica, Rajnish Nagarkar, Larry Kwak, Won-Seog Kim, SangJoon Lee, SungHyun Kim, KeumYoung Ahn, Michinori Ogura
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3354–3361.
https://doi.org/10.1182/bloodadvances.2021004484
Published: 2021
Includes: Supplemental data
Journal Articles

Zanubrutinib for the treatment of relapsed or refractory mantle cell lymphoma

Clinical Trials & Observations
Constantine S. Tam, Stephen Opat, David Simpson, Gavin Cull, Javier Munoz, Tycel J. Phillips, Won Seog Kim, Simon Rule, Siminder Kaur Atwal, Rachel Wei, William Novotny, Jane Huang, Michael Wang, Judith Trotman
Journal: Blood Advances
Blood Adv (2021) 5 (12): 2577–2585.
https://doi.org/10.1182/bloodadvances.2020004074
Published: 2021
Includes: Supplemental data
Journal Articles

A risk model for relapsed/refractory aggressive NHL integrating clinical risk factors and pretransplant Deauville score

Clinical Trials & Observations
Ho-Young Yhim, Yael Eshet, Ur Metser, Chae-Hong Lim, Katherine Lajkosz, Keren Isaev, Matthew Cooper, Anca Prica, Vishal Kukreti, Sita Bhella, Noémie Lang, Kyung-Han Lee, Wei Xu, David Hodgson, Richard Tsang, Sang Eun Yoon, Seok Jin Kim, Won Seog Kim, Michael Crump, John Kuruvilla, Robert Kridel
Journal: Blood Advances
Blood Adv (2020) 4 (22): 5762–5771.
https://doi.org/10.1182/bloodadvances.2020002814
Published: 2020
Includes: Supplemental data
Journal Articles

Progression of AITL-like tumors in mice is driven by Tfh signature proteins and T-B cross talk

Mariko Witalis, Jinsam Chang, Ming-Chao Zhong, Yasser Bouklouch, Vincent Panneton, Joanna Li, Thorsten Buch, Seok Jin Kim, Won Seog Kim, Young Hyeh Ko, André Veillette, Woong-Kyung Suh
Journal: Blood Advances
Blood Adv (2020) 4 (5): 868–879.
https://doi.org/10.1182/bloodadvances.2019001114
Published: 2020
Includes: Supplemental data